| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102695
Status
Published
Date of creation
2011-11-05 12:52 UTC (mratanak123@hotmail.com)
Date of publication
2011-11-05 12:52 UTC (mratanak123@hotmail.com)

Origin of report
Country
  • Cambodia
Contact officer for report
Coordinates
Mr Pisey Oum
CPB National Focal Point
Ministry of Environment (MoE)
#48, Preah Sihanouk Blvd, Tonle Bassac, Chamkarmon.
Phnom Penh
Cambodia
Phone:(855) 23 217 560
Fax:(855) 23 217 560
Email:piseyoum@hotmail.com,sec_nscb@hotmail.com
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
Relevant Ministries, NGOs, academic institutions, and researchers
Submission
10. Date of submission
2011-11-05
11. Time period covered by this report
Start date
2011-07-01
Time period covered by this report
End date
2011-09-30
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is fully in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
  • One or more national biosafety regulations
  • One or more sets of biosafety guidelines
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • More than 10
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Yes
21. Here you may provide further details on the implementation of Article 2 in your country:
As a Party to the Cartagena Protocol, Cambodia has implemented a program to address the risks identified with biotechnology through a hierachy of measures - regulations, management or other means of control (Cambodia NBSAP, 2002). Cambodia has developed a policy on biotechnology and biosafety which lies within the biodiversity policy as outlined in the national biodiversity strategy and action plan. The policy is a part of the strategic triangle in developing the country. The goal for Cambodia toward biosafety and biotechnology development is highlighted as follow:
1- Development biotechnology education while preventing or minimizing environmental and health hazard associated with the use and release of LMOs.
2- Protect indigenous biodiversity from adverse impact resulting from the introduction and use of LMOs.
Under the UNEP/GEF funded project, Cambodia produced a national Law on Biosafety and a Sub-Decree on Mechanism and Procedures for Implementing the law on Biosafety biosafety. This law consist of 45 articles dealing with the transboundary movement of LMOs and risk assessment and management mechanism for the release of LMOs into the environment. The law approved on 28 December 2007 and promulgated on 15 February 2008.
Sub-decree on Mechanism and Procedures for Implementing the Law on Biosafety aproved on 21 June 2010. The objective of this sub-decree are to implement the national law on biosafety and to provide a transparent process for review and decision-making on LMOs and related activities. This sub-decree consist of 66 articles regulating risk that might occur from handling, transfer, transport and use of LMOs in Cambodia.  
National Action PLan on Biosafety and Biotechnology (2010-1014) approved on 10 December 2010 which were identified 6 priority components including (i) Policy, Regulation and Standard Development, (ii) Information and Prospective Analysis, (iii) Capacity Building, (iv) Research and Development, (v) Commercialization and Trade and (vi) Public Awareness, Education and Participation. Each component has been allocated the budget sources from the Government/Donor Communities to support for implementation The strategy aims to develop and pratice safe use of biotechnology in Cambodia, mainly focusing on modern biotechnology ensuring the application of LMOs' products to improve agricultural activity, poverty reduction, public health improvement and economic growth, and the protection of national biodiversity.
Cambodia's guideline for risk assessment and risk management of LMOs developed in May 2008.. The objective of this guideline is to provide guidance for assessors and decision makers in conducting risk assessment and risk management of LMOs release into the environment, importation of LMOs, development, packaging, contained use, transfer and field testing.
All documents as mentioned above are available on the Cambodia BCH website.
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
The scope of national law on Biosafety shall not apply to (i) LMOs that pharmaceuticals for human use that addressd by relevant international agreements and/or organizations; (ii) living modified organisms in transit through but not destined for use in Cambodia (iii) any other categories of LMOs that may be exempted by the National Competent Authority; (iii) any processed products containing dead modified organisms or non-living components of genetically modified organisms.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • Yes
26. Does your country regulate the contained use of LMOs?
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • Yes
28. Here you may provide further details on the implementation of Article 6 in your country:
The scope of national law on biosafety shall not apply to LMOs in transit through but not destined for use in the Kingdom of Cambodia (see answer of question 24).
The scope of this law shall apply to the import and export, contained use, intentional introduction into the environment, and direct use as food or feed or for processing of LMOs that may have an adverse effect on the conservation and sustainable use of biological diversity, taking also into account risks to human health.
All information have been submitted to BCH and available on BCH website.                                             
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • Yes
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • Yes
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
32. If you answered Yes to question 31, does the mechanism also apply to cases of intentional introduction of LMOs into the environment that were not subject to transboundary movement?
  • Yes
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • Yes
34. Does your country have the capacity to detect and identify LMOs?
  • No
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • Yes
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • Yes
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Not applicable
39. If you answered Yes to question 38, how many LMOs has your country approved to date for import for intentional introduction into the environment?
  • Not applicable
40. If you answered Yes to question 38, how many LMOs, not imported, has your country approved to date for intentional introduction into the environment?
  • Not applicable
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
Procedures for authorizing LMO application has addressed in the National Law on Biosafety (2008), which require all applicantions, shall be submitted to the Ministry of Environment in order to get prior approval letter as it will be discussed among members of the National Steering Committee for Biosafety and risk assessment review by the Scientific Advisory Team. This law elaborated the procedure for import and export of LMO products to and from Cambodia under Chapter III, article 10 to article 16 and Chapter IV, article 17 to article 19.
In article 5 and article 7 under Chapter II of the Sub-decree on Mechanisms and Procedures for Implementing the Law on Biosafety, National Steering Committee for Biosafety will be established, and chaired by Minister of Environment which consist of 16 representatives from most relevant agencies. The roles and responsibilities of this committee are to control and monitor the obligation on Cartagena Protocol on Biosafety's implementation and other duties.
In article 8 under Chapter II of this sub-decree, Emergency Response Team will be established and chaired by Ministry of Environment which consits of 10 representatives from relevant agencies. The roles and responsibilities this team are to detect LMOs that exposed into the environment or leaked from use, transport and reporting the risks or this incidence and damages and other functions. But this team have no capacity for conducting LMOs detection. It was required to organise several training courses on this topic.
In article 43 of Chapter VI of this sub-decree, it stated that a written notification to the competent national authority of the proposed country of export shall include information specified in Annex I of this sub-decree. The information described in the notification as mentioned in the above paragraph shall be certified as correctness by the Ministry of Environment.
In article 5 of the law on biosafety, it stated that any legal or natural person responsible for any activity or operation involving LMOs covered by this law shall ensure that contained use, intentional introduction into the environment, direct use as food, feed or for processing, import, and export of LMOs is carried out in conformity with this law and all sub-decrees implementing this law by, among other things:
1- Developing a risk management strategy,
2- Providing an emergency response plan for aacidential release,
3- Establishing mechanisms for internal monitoring of safety,
In article 24 of the sub-decree, it pointed out that any legal or natural person who imports LMOs into the Kingdom of Cambodia for intentional introduction into the environment shall be subject to risk assessment and prior approved by the Ministry of Environment before applying to the concerned competent ministries for the import permit. .
Now, Cambodia is on process to establish Secretariat of National Steering Committee for Biosafety (NSCB) as stated in article 11 of this sub-decree and Scientific Advisory Team that has role to review risk assessment that accompany requests for prior approval to apply for an import/export permit and recommending to the Ministry of Environment whether additional risk assessment is required. Therefore, receiving an application/notification regarding intentional transboundary movement of LMOs for intentional introduction into the environment is not yet happened in Cambodia.                                                   
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • Yes
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • Yes
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • Yes
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • No
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
In artcile 29 under Cpater III of this sub-decree, it stated that the first import into the Kingdom of Cambodia, any LMO for direct use as food, feed or for processing shall be subject to risk assessment and approved by the Ministry of Environment prior to application to the concerned competent ministries for the import permit.
In article 30 under Chapter III of this sub-decree, the applicant shall include following information in its request for prior approval: i) the information specified in Annex II, ii) the comprehensive report of a risk assessment carried out in conformity with Annex III of this sub-decree, and iii) any additional information which the applicant deems relevant to an assessment of the potential risk and/or benefit of the intended direct use for food of feed or for processing.
In article 32 under Chapter III of this sub-decree, it said that if the applicant make a correction of the document or any information in the application, the applicant shall submit such document or information to the Ministry of Environment within 90days. After reviewing comments and Scientific Adsory Team report, the Ministry of Environment shall communicate in writin to the applicant and to the Biosafety Clearing-House its decision, including either: i) its approval and authorization to apply for an import permit, with or without conditiond, including how the approval will apply to subsequent imports of the same LMO or ii) denial or approval of the proposed import.
In article 34 under Chapter III of this sub-decree, when the Ministry of Environment approves a LMO for direct use as food or feed or for processing, it shall inform other parties to the Cartagena Protocol throug the Biosafety Clearing-House within 15 days. This information shall contain at a minimum the information specified in Annex II of this sub-decree.
In activity 3.2. under Chapter 3 of National Action Plan on Biosafety and Modern Biotechnology, it was required to establish and/or enhance exiting laboratories for biotech development and LMOs detection or establish a new lab (if necessary) with budget allocation and technical assistance. The action plan requires USD9.73 million over a period of 5 years (2010-2014).
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • Yes
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
In article 29 under Chapter VIII of the Law on Biosafety, the Ministry of Environment and concerned ministries may review any decision on activities, operations, import or export at any time on obtaining significant new information indicating that the LMOs or te activities, operations, import or export involved may adversely affect the conservation and sustainable use of biodiversity, taking also into account risks to human health. When the Ministry of Environment revises any decision on an LMO covered by this law it shall inform the Biosafety Clearing-House.
In artcile 30 under Chapter VIII of this law, if the Ministry of Environment changes a decision approving import of any LMO for any purpose, the Ministry of Environment shall, within 30 days, inform the applicant that has previously applied for and/or received approval to import the LMO of the reasons for its revised decision.                                                      
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
For all imports and utilizations of LMOs, as specified in the Chapter IV and Chapter V of this sub-decree, an application shall submit a request to the Ministry of Environment for prior approval and shall submit all relevant documents of LMOs to the Ministry of Environment. All requests for prior approval shall include a sworn declaration that the information contained in the requests is correct. An applicant may withdraw the request for prior approval prior to the issuance of a decision by the Ministry of Environment.                                                      
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • Yes
78. If you answered Yes to question 77, has your country informed the Parties through the BCH of the agreements or arrangements?
  • In some cases only
79. If you answered Yes to question 77, please provide a brief description of the scope and objective of the agreements or arrangements entered into:
Cambodia is a member state of ASEAN and is subject to comply with ASEAN Regional binding agreement and decisions.                                                     
80. Here you may provide further details on the implementation of Article 14 in your country:
In article 5 under Chapter II of this sub-decree, it clearly stated on the roles and responsibilities of National Steering Committee for Biosafety (NSCB) that the NSCB shall establish the relation between the Royal Government of Cambodia (RGC) and the Secretariat of Convention of Biodiversity for strengthening the implementation on Cartagena Protocol on Biosafety and advise the  RGC on the protocol and draft agreements that related to CPB's implementation. Furthermore, the NSCB shall control and encourage the international and institutional cooperation on biosafety issues.                                                      
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes
82. If you answered Yes to question 81, does this mechanism include procedures for identifying experts to conduct the risk assessments?
  • Yes
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • Yes
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • Yes
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • Yes
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Not applicable
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • Not applicable
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • Not applicable
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Not applicable
93. Here you may provide further details on the implementation of Article 15 in your country:
In artcile 20 under Chapter V of the law on biosafety, the Ministry of Environment shall ensure that appropiate risk assessments are carried out for all actions related to LMOs that require a prior approval.
The scientific advisory team (experts team) will conduct a risk assessment based on the dossier provided by the applicant (s). In case, there is insufficient information for risk assessment, the scientific adsory group has the right to request for further information. After 270 days of accepting application, the Ministry of Environment shall inform in written to the applicant and mass media about their decision. Such decision shall indicate the approval (with or without condition) or rejection of the application as stated in No.3 under Chapter 1 of national action plan on biosafety and modern biotechnology.
In activity 3.3 under Chapter 3 of this action plan, it stated to establish scientific adsory group and provide them with appropriate knowledge on LMOs related issues.
In article 21 under Chapter V of this law, the exporter/applicant shall carry out the risk assessment and shall bear all related costs. Upon receipt of the results of the risk assessment and other documentation required under this law, the Ministry of Environment may grant approval with or withrow conditions, request additional information, or deny approval.
Cambodia's Guideline for Risk Assessment and Risk Management of LMOs was developed and published in May 2008, as part of a technical assistance project facilitated by the United Nation Environment Project (UNEP) and financed by the GEF through a project on Cambodia Implementation of the National Biosafety Framework Project (GEF/-2328-2716-4634). The purpose of this guideline is to provide guideline for assessor, officers and decision makers in conducting risk assessment and risk management of LMOs release into the environment, importantce of LMOs, development, packaging, contained use, transfer and field testing.                                                    
The Training Manual on Risk Assessment and Risk Management was developed and published in December 2008 as part of technical assistance project facilitated by the UNEP and financed by the GEF through a project on Cambodia Implementation of the National Biosafety Framework Project (GEF/-2328-2716-4634) with in-kind contributions from the Royal Government of Cambodia. The purpose of this manual is to provide awareness on RA and RM to the officers from different governmental institutions, acedemic institutions and NGOs. This manual focuses specifically on the methodology for conducting RA and RM of LMOs. Its aim is to promote a holistic understanding of these components so that trainees, especailly government officers can participate in undertaking RA and RM.
Nowadays, Cambodia is on process to establish a Secretariat of NSCB, which will function adaministrative tasks, i.e. to receive applications of LMOs for various uses,  information other parties, applicants on LMOs release into the environment. Therefore, the conducting RA and RM of an LMO intentional introduction and LMO intended for direct use as food or feed, or for processing is not yet carried out.
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • Yes, to some extent
94.2) LMOs intended for direct use as food or feed, or for processing?
  • Yes, to some extent
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • No
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • Yes
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
In article 53 to article 56 under Chapter VIII of this sub-decree, it elaborates the procedure for risk assessment management resulting from LMO application, in which article 53 stated that whenever there are accidentally leakage or exposure of LMOs, the applicant or person who in charge on transportation or the happened place shall reporting to the Ministry of Environment in emergency.
In activity 1.1. under Chapter 3 of national action plan on biosafety and modern biotechnology, it pointed that develop and implement safety standards for LMOs application (import, trial, food, feed and processing).
In activity 3.4.1 under Chapter 3 of this action plan, it state that establish emergency response team as a mechnism to mitigate risk caused by outreak of LMO product.
In artcile 3 under Chapter II of this law, it state that this law shall apply to the import and export, contained use, intentional introduction into the environment, and direct use as food or feed or for processing of LMOs that may have an adverse effect on the conservation and sustainable use of biological diversity, taking also into account risks to human health.
In article 6 under Chapter II of the law on biosafety, it said that in collaboration with other concerned ministries, the Ministry of Environment shall manage and control all activities and operations involving LMOs covered by this law. The Ministry oif Environment shall be the National Focal Point and National Competent Authority for implementing the provisions of this law and those of the Cartagena Protocol.
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • No
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
In article 8 under Chapter II of this sub-decree, Emergency Response Team will be established with the main functions and responsilibities i) to detect LMOs that exposed into the environment or leaked from use, transport and reporting the risks or this incidence and damages, ii) obtain information and take urgent measures whenever there accidently leakages or exposure of LMOs to curb or minimize the magnitude of damages on biological diversity and human health, iii) training for relevant technical officials on measures and iv) fulfill other duties that the National Steering Committee for Biosafety (NSCB) assigned.
The NSCB chairman shall have the right to directly order the Emergency Response Team to take measures at appropriately urgent time as stated in article 10 under chapter II of this sub-decree. Now, Cambodia is on process to establish the emergency response team.
In activity 2.1. under Chapter 3 of the national action plan on biosafety and modern biotechnology, it is to develop biotechnology database system that can be accessed by all interested entities and revise and update existing information sharing system including contact points giving an indicateion of the area of experise and research (Camodia BCH for the public).
In artcile 7 under Chapter II of the law on biosafety, as the national focal point stated in article 6, the Ministry of Environment shall be the primary contact between the Royal Government of Cambodia and the Secretariat of the Cartagena Protocol.
As the national focal point, the Ministry of Environment shall be responsible for the administrative functions required to implement this law. These functions shall include timely notification to other states, the biosafety clearing-house, and relevant international organizations of any event in the Kingdom of Cambodia that may result in the unintentional trans-boundary movement of an LMO.
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • Yes
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • Yes
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • Yes
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • Yes
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
114. Has your country established procedures for the sampling and detection of LMOs?
  • No
115. Here you may provide further details on the implementation of Article 18 in your country:
In article 1 under Chapter I of this law, the objective of this law is to prevent adverse impact on the conservation of biodiversity and natural resources in the Kingdom of Cambodia cuased by the transboundary movement, development, handling, transfer, use, storage, and release of LMOs resulting from modern biotechnology.
In article 22 under Chapter VI of this law, any legal or natural person who imports LMOs into or exports LMOs from the Kingdom of Cambodia for any purpose shall provide accompaying documentation that clearly identifies them as LMOs and specifies any requirements for their safe handling, transport, use and staorage.
In artcile 23 under Chapter VI of this law, it states that except any law or regulations otherwise specify, LMOs that are imported into or exported from the Kingdom of Cambodia shall be accompanied during transboundary movement and upon delivery to the port of entry by documentations shall cover:
1- LMOs for direct use as food or feed or for processing, clearly identify that the goods may contain LMOs and are not intended for intentional introduction into the environment,
2- LMOs for intentional introduction into the environment, specify their identify and relevant characteristics and any requirements for their safe handling, transport, use and storage, specifies the contact point for further infornation, and also states that the transboundary movement is in conformity with requirements of Cartagena Protocol applicable to the exporter,
3- LMOs for contained use, clearly identify them as LMOs, specify any requirements for their safe handling, transport, use and storage, and specify the contact point for further information including the name and address of the individual and the institution to which the LMOs are consigned.
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes
123. Here you may provide further details on the implementation of Article 19 in your country:
A National Focal Point for CPB and a National Focal Point for BCH have been desingated. Further information can be reach via: #48, Samdech Preah Sihanouk Ave.; Khan Chamkaromon, Phnom Penh, Cambodia. Tel and Fax: +855-23-217560; hand phone: +855-97-6725859; email: piseyoum@hotmail.com or sec_nscb@hotmail.com 
In artcile 6 under Chapter II of this law, the Ministry of Environment shall be the National Focal Point and National Competen Authority for implementing the provisions of this law and those of the Cartagena Protocol.
In artcile 8 under Chapter II of this law, the Ministry of Agriculture, Forestry and Fishery shall be the chairperson of Scientific Adsory Team (SAT) and has its office in the Ministry of Agriculture, Forestry and Fishery.
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available and in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available and in the BCH
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information available and in the BCH
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information available and in the BCH
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information available and in the BCH
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information available and in the BCH
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • Yes
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • No
128. Has your country experienced difficulties accessing or using the BCH?
  • No
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • No
130. Is the information submitted by your country to the BCH complete and up-to date?
  • Yes
131. Here you may provide further details on the implementation of Article 20 in your country:
Under the implementation of the national biosfaety framework project, funded by UNEP/GEF, the Ministry of Environment has produced a lot of outputs such as law on biosafety, sub-decree on mechanism and procedure for implementing law on biosafety, national action plan on biosfaety and biotechnology,Cambodia's guideline for risk assessment and risk management of LMOs, training manual on monitoring, compliance and enforcement of transboundary movement of LMOs, and training manual on risk assessment and risk management of LMOs, etc. Thsese documents are available on BCH.
In section III under Chapter IV of the sub-decree from article 29 to article 36, it was elaborated the import for direct use as food, feed or for processing and the subdecree is avialble on BCH website.
The contact detail for National focal point and national competent authority is the Ministry of Environment stated in article 6 and artcile 7 under Chapter II of the law on biosafety. The contact for emergency response is the Ministry of Environment a stated in article 10 under Chapter II of the sub-decree. The law is avaliable on BCH.
In artcile 58 under Chapter VIII of the sub-decree, the Ministry of Environment shall disseminate information regarding requests for prior approval to import into the Kingdom of Cambodia LMOs for contained use, intentional introduction into the environment and/or does not for direct use as food or feed or for processing. The sub-decree is available on BCH.
In article 59 under Chapter VIII of the sub-decree, the Ministry of Environment shall make available to the public any information that does not qualify as confidential under article 25 of the law on biosafety.
  Cambodia has established the Biosafety Clearing-House task force  and national  BCH was developed and updated to enhance information flow on LMOs application and its approval.
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • In some cases only
134. Here you may provide further details on the implementation of Article 21 in your country:
From article 45 to article 52 under Chapter VII of this sub-decree, it elaborated the confidential information, in which, the Ministry of Environment shall request to the applicant to provide further information, which the applicant considered that it is the confidential information such as the information on announcement letter or on the documentary of the permitted request for import of LMO for keeping confidentiality.
In the case of stated above, the Ministry of Environment has right to make decision for approval or not approval to consider as the confidential information which was indicated by the applicant, providing the suitable reason to the applicant.
The confidential information is information which could not be flowed without permission.
The information was considered as confidential information unless the information consists of the follow key points:
1- The information was kept as confidentiality from any one, even, the person works with te source of information
2- The information is valuable for commerce, and
3- The information which the applicant shall has appropriate measure for keeping it.
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Multilateral channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Average
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Implementation of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
  • Building Capacity for Effective Participation in the BCH (Phase II)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Taking into account risks to human health
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • Yes
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
In article 1 under Chapter I of the law on biosafety, the objective is to develop biotechnology education while preventing environmental and health associated with the use and release of LMOs.
In component 3 of national action plan on biosafety and biotechnology, it elaborated that capacity building is required in order to carry out the proposed research and development agenda, and transfer the developed innovations into the market place, while keeping ministries/institutions and the general public aware of these developments. This process has been occurring at a steady pace throughout Cambodia but efforts may be unsatisfactory it duplications, redundancies and lack of sufficient monetary support occur. The process of capacity building can be simplified by adopting a regional or international approach, taking into account the need to strengthen national programs.
Under the UNEP/GEF funded project on implementation of National Biosafety Framework, the Ministry of Environment has conducted the survey on national capacity resources, uses of biotechnologies and existing national bilateral and multilateral cooperative programes on capacity buidling and reasearch and development in biotechnology in Cambodia.
Two projects on Development of National Biosafety Framework and Implementation of National Biosafety Framework were technical supported and funded by UNEP/GEF for Cambodia since 2004.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes
152. Has your country established a biosafety website?
  • Yes
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • No
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • No
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • No
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • Yes
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • Yes
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
From article 32 to article 34 under Chapter IX of the law on biosafety, it elaborated the public awareness and participation, in which the Ministry of Environment and other concerned ministries shall promote awareness and education for the general public and encourage public to particiupate and provide feedback in planning and decision making process relevant to biosafety issues.
From article 57 to article 60 under Chapter IX of the sub-decree, it also elaborated the public information, awareness-raising and participation, in which the Ministry of Environment and other concerned competent ministries shall promote awareness of and education to the general public, with special attention to those conducting activities and operations concerning biosafety through dissemination of law on biosafety and regulation to implement the law on biosafety.
In article 7 under Chapter II of the sub-decree, the role and responsibility of national steering committee for biosafety is to encouarge for public awareness on developing national biosafety framework needed.
In component 6 of the national action plan on biosafety and modern biotechnology, it stated that it is essential to inform the public of the uses and weaknesses of modern biotechnology and biosafety to ensure safe use of this very useful but still new and young technology in Cambodia, and also to develop educational guides and programs to ensure the continuity of effort. The objectives of this component are i) to increase public awareness of the potentail risk of biotechnology and potential benefit of biotechnology, ii) to encourage cooperation between ministries and universities with regional universities for technology transfer and iii) to increase formal and informal education on biosafety and modern biotechnology.
Under UNEP/GEF funed project on implementation of national biosafety framework, the Ministry of Environment has organized several trainings, workshops, debath on TV on public awareness on biosafety and environment. Furhtermore, the Ministry of Environment has produced materials for public awareness such as newslaters, brochures, k-pockets on biosafety, etc.
Website Cambodia BCH was established (http://www.cambodiabiosafety.org) and the public can access to the website.
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
167. Here you may provide further details on the implementation of Article 24 in your country:
The law on biosafety and sub-decree on mechanism and procedure for implementing law on biosafety doesn't deal with Non-Parties for export and import of LMOs in Cambodia.
Up to now, Cambodia never import LMOs from Non-Paties into the country. Import of LMOs products in forms of pharmaceuticals might have happended through different mandates.
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • No
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • Yes
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
In component of 5 of actional action plan on biosafety and biotechnology, it elaborated the establishment of biotechnology products and process control system (biosafety and biotechnology control system), in which Cambodia shall develop methodology to prohibit the import of LMOs products into its market under strong condition of commercialization such as checking points at border, measure to control infect disease through import of animal or plants species by person and measure to control risk on health, etc.
In activity 5.2.2. under component 5 of this action plan, it stated that Cambodia shall establish plan/animal quarantine office at check points and effective implement and install equipment for detection of restricted species.
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Only in some cases
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
178. Here you may provide further details on the implementation of Article 26 in your country:
In component 5 of national action plan on biosafety and modern biotechnology, it elaborated that Cambodia should be mainly focused on modern biotechnology to support agriculture sector towards to improve products for import of agricultural products, agr-indutrsies, and social development which consist with protection of agricultural products in counstry. The objective of this component is to support the development of a harmonized intellectual properties rights.
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • Yes
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
Translation of the supplementatry protocol was done in Khmer.
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • Not Applicabe
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
Country has established a biotechnology lab to analyze and detect LMOs imported into the country as to support decision-making for issuing the prior approval letter.
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
This report format is fine to be filled and take short time but with a considerable time for consultation.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2008
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • 1 per year or more
Here you may provide further details
Between 2-5 training were organized.
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • No
Here you may provide further details
We are training to establish data entry person in relevant agencies to ensure the flow of data.
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 5,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • No
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • Yes
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • Yes
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • Yes
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • No
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • No
Survey 13.c) Monitor
  • No
Here you may provide further details
Capacity to monitor has some.
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • No
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • No
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • None
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
None.
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • No
Here you may provide further details
But to some extend, Cambodia has some capacity and institution to deliver measures.
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • 50 or more
Survey 19.b) Monitoring
  • 10 or more
Survey 19.c) Management / Control
  • One or more
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • Yes
Here you may provide further details
Cambodia has Biotechnology lab to identify LMO and conduct a strip test.
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • Yes
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • No
Survey 22.b) Effective
  • Yes
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • 50 or more
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • One or more
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • No
Here you may provide further details
We are focusing on building capacity of our lab to detect LMOs.
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • None
Here you may provide further details
Only one lab at MOE is operating LMOs detection.
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • One or more
Here you may provide further details
One lab at MOE
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • No
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • No
Here you may provide further details
We are drafting the law on Liability and Redress pursuant to LMOs
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • Yes
Here you may provide further details
Based on Biosafety Law in 2008
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • National website
  • Public hearings
Survey 32. If you indicated multiple modalities for public participation in the question above, which one was most used?
indicator 2.5.2
  • National website
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • One or more
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • One or more
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • No
Here you may provide further details
Enforcement system is in operating.
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • One or more
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • One or more
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • National website
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • One or more
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • Yes
Here you may provide further details
Video spot, youth debate, brochures and newsletters.
Survey 41. If you answered yes to the question above, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place.
indicator 5.3.1
E.g. local, national, etc.,
Secretariat for the National Steering Committee for Biosafety
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • Yes
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • One or more